公开(公告)号：WO2017064555A1

公开(公告)日：2017-04-20

申请号：PCT/IB2016/001528

申请日：2016-10-05

Applicant: SEINDA BIOMEDICAL CORPORATION

Inventor： HUANG, Jing-feng

IPC: G01N33/53

CPC classification number: G01N33/6869 ,  G01N33/6863 ,  G01N33/6893 ,  G01N2333/535 ,  G01N2333/5403 ,  G01N2333/5406 ,  G01N2333/5428 ,  G01N2800/16 ,  G01N2800/24 ,  G01N2800/245 ,  G01N2800/50 ,  G01N2800/52

Abstract: Provided are methods, kits, and devices for diagnosing and monitoring dry eye disease in a subject. The methods comprise measuring in a sample from the subject a level of at least one biomarker selected from the group consisting of TNF α, IL-4, IL-3, IL-10, GM-CSF, IL-13, IL-5, and IL-9, and/or any derivative, fragment, or precursor of the biomarkers.

Abstract translation: 提供了用于诊断和监测受试者的干眼病的方法，试剂盒和设备。 该方法包括测量来自受试者的样品中至少一种选自TNFα，IL-4，IL-3，IL-10，GM-CSF，IL-13，IL-5， 和IL-9，和/或生物标记的任何衍生物，片段或前体。

公开(公告)号：WO2017064555A9

公开(公告)日：2017-04-20

申请号：PCT/IB2016/001528

申请日：2016-10-05

Applicant: SEINDA BIOMEDICAL CORPORATION

Inventor： HUANG, Jing-feng

IPC: G01N33/53

Abstract: Provided are methods, kits, and devices for diagnosing and monitoring dry eye disease in a subject. The methods comprise measuring in a sample from the subject a level of at least one biomarker selected from the group consisting of TNF α, IL-4, IL-3, IL-10, GM-CSF, IL-13, IL-5, and IL-9, and/or any derivative, fragment, or precursor of the biomarkers.